1 results match your criteria: "University of Washington bFred Hutchinson Cancer Research Center[Affiliation]"
131I-tositumomab myeloablative radioimmunotherapy for non-Hodgkin's lymphoma: radiation dose to the testes.
Nucl Med Commun
December 2012
aDepartment of Radiology, Division of Nuclear Medicine, University of Washington bFred Hutchinson Cancer Research Center, Seattle cPacific Northwest National Laboratory, Richland, Washington, USA.
Article Synopsis
- The study examined how radiation from a specific treatment affects testosterone levels in male patients with non-Hodgkin's lymphoma.
- The research involved tracking radiation doses in the testes of 67 male patients and measuring hormone levels before and one year after treatment.
- Results indicated significant variability in radiation doses, with those receiving higher doses experiencing a notable decrease in testosterone levels post-therapy.